Safety in paediatric clinical trials - A 7-year review

Acta Paediatrica, International Journal of Paediatrics

Volumn 97, Issue 4, 2008, Pages 474-477

  Sammons, H M ^a   Gray, C ^a   Hudson, H ^a   Cherrill, J ^a   Choonara, I ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Adverse drug reaction; Child; Clinical trial

Indexed keywords

DEXAMETHASONE; DIAZEPAM; MIDAZOLAM; PHENOBARBITAL; PINDOLOL; PLACEBO; VIGABATRIN;

ADVERSE OUTCOME; ARTICLE; CHILD HEALTH; CHILDHOOD MORTALITY; CHRONIC LUNG DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE SEVERITY; DRUG SAFETY; EPILEPTIC STATE; FATALITY; HOSPITALIZATION; HUMAN; PATIENT SAFETY; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; VISUAL FIELD DEFECT;

CHILD; CLINICAL TRIALS AS TOPIC; CLINICAL TRIALS DATA MONITORING COMMITTEES; DRUG THERAPY; HUMANS; PEDIATRICS; SAFETY;

EID: 41149145228     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2008.00676.x     Document Type: Article

References (30)

1. Conroy S, Choonara I, Impicciatore P, Mohn A, Henrik A, Rane A, et al. Survey of unlicensed and off-label drug use in paediatric wards in European countries. BMJ 2000 320 : 79 82.
2. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Neonatal Ed 1999 80 : F142 5.
3. Mcintyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label prescribing of drugs in general pratice. Arch Dis Child 2000 83 : 498 501.
4. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998 316 : 343 5.
5. Spielberg S. Therapeutics in the USA, internationally and unparalled opportunity. Paediatr Perinat Drug Ther 2000 4 : 71 4.
6. Saint Raymond A, Seigneuret N. Medicines for children: time for Europe to act. Paediatr Perinat Drug Ther 2005 6 : 142 6.
7. Choonara I, Rieder MJ. Drug toxicity and adverse drug reactions in children - a brief historical review. Paediatr Perinat Drug Ther 2002 5 : 12 8.
8. Choonara I. Clinical trials of medicines in children. BMJ 2000 321 : 1093 4.
9. Roberts R, Rodriguez W, Murphy D, Crescenzi T. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA 2003 290 : 905 11.
10. Sammons HM, Choonara I. Clinical trials of medication in children. Eur J Clin Pharmacol 1996-2002 61 : 165 7.
11. Hargrave DR, Hann IM, Richards SM, Hill FG, Lilleyman JS, Kinsey S, et al. Progressive reduction in treatment related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997. Br J Haematol 2001 2001 : 293 99.
12. Nolan ML, Greenberg AE, Fowler MG. A review of clinical trials to prevent mother-to-child HIV-1 transmission in Africa and inform intervention strategies. AIDS 2002 16 : 1991 9.
13. Edwards SD, Mcnamee MJ. Ethical concerns regarding guidelines for the conduct of clinicalresearch on children. J Med Ethics 2006 31 : 351 4.
14. European Medicines Evaluation Agency. Note for guidance on structure and content of clinical study reports. CPMP/ICH/137/95.
15. Kennedy CR, Ayers S, Campbell MJ, Elbourne D, Hope P, Johnson A. Randomized, controlled trial of acetazolamide and furosemide in posthemorrhagic ventricular dilation in infancy: follow up at 1 year. Pediatrics 2001 108 : 597 607.
16. Schmidt B, Gillie P, Mitchell L, Andrew M, Caco C, Roberts R. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Resp Crit Care Med 1998 158 : 470 6.
17. Vaughn PR, Townsend SF, Thilo EH, McKenzie S, Moreland S, Kawato K. Comparison of continuous infusion of fentanyl to bolus dosing in neonates after surgery. J Pediatr Surg 1996 31 : 1616 23.
18. Splinter WM, Rhine EJ, Roberts DW, Reid CW, MacNeill HB. Preoperative ketorolac increases bleeding after tonsillectomy in children. Can J Anaesth 1996 43 : 560 3.
19. Kishiyama JL, Valacer D, Cunningham-Rundles C, Sperber K, Richmond GW, Abramson S, Glovsky M, et al. A multicenter, randomized, double-blind placebo-controlled trial of high dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol 1999 91 : 126 33.
20. Lindberger M, Alenius M, Frisen L, Johannessen SI, Larsson S, Malmgren K, Tomson T. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. Epilepsia 2000 41 : 1289 95.
21. de Silva M, MacArdle B, McGowan M, Hughes E, Stewart J, Neville BGR, Johnson AL, et al. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996 347 : 709 13.
22. Buitelaar JK, van der Gaag RJ, Swaab-Barneveld H, Kuiper M. Pindolol and methylphenidate in children with attention deficit hyperactivity disorder. Clinical efficacy and side effects. J Child Psychol Psychiatry 1996 37 : 587 95.
23. Romagnoli C, Zecca E, Vento G, De Carolis MP, Papacci P, Tortorolo G. Early postnatal dexamethasone for the prevention of chronic lung disease in high risk preterm infants. Intensive Care Med 1999 25 : 717 21.
24. Romagnoli C, Zecca E, Vento G, De Carolis MP, Papacci P, Tortorolo G. Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. Pharmacology 1999 59 : 266 74.
25. Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, Kao HA, et al. Early postnatal dexamethasone therapy for the prevention of chornic lung disease in preterm infants with respiratory distress syndrome: a multicentre clinical trial. Pediatrics 1997 100 : E3.
26. Singhi S, Murthy A, Singhi P, Jayashree M. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol 2002 17 : 106 110.
27. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001 52 : 77 83.
28. Collins GE, Clay MM, Falletta JM. A prospective study of the epidemiology of adverse drug reactions in pediatric hematology and oncology patients. Am J Hosp Pharm 1974 31 : 968 75.
29. Tait AR, Voepel-Lewis T, Malviya S. Factors that influence parents' assessments of the risks and benefits of research involving their children. Pediatrics 2004 113 : 727 32.
30. van den Ouweland FA, Brown E, Carr DJ. Data monitoring committees in paediatric research. Paediatr Perinat Drug Ther 2004 6 : 81 8.